Aarti Drugs Q4FY22 Quarter Results

Aarti Drugs net revenues grew 39% YoY in Q4FY22.
  • 09 May 2022
  • Aarti Drugs consolidated revenues for the quarter ended December (Q4FY22) were up 9% quarter-on-quarter (QoQ). On a year-on-year (YoY) basis, it witnessed a growth of 39%.
  • Its expenses for the quarter were up 11% QoQ and 43% YoY.
  • While the company reported 5% QoQ net profit decline, the same was up by 7% on a YoY basis.
  • The earnings per share (EPS) of Aarti Drugs stood at 6 during Q4FY22.

Aarti Drugs Financial Statements for Q4FY22:

(Rs, crores) Q4FY21 Q3FY22 Q4FY22 QoQ (%) YoY (%)
Total Income5036416979%39%
Total Expenses43756362711%43%
Profit before tax657971-10%8%
Profit after tax525855-5%7%
Earnings per share5.56.36.0

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Open Demat Account
or Resume your Application
+91 -